XENON PHARMACEUTICALS INC. (XENE) Operating margin 2016–2025
XENON PHARMACEUTICALS INC. (XENE) operating margin by fiscal year — reported operating income divided by reported revenue.
-4974.3%FY2025 · since FY2016: -1376.4% → -4974.3%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -4974.3% | — |
| FY2022 | -1368.9% | -940.5 pp |
| FY2021 | -428.4% | -331.1 pp |
| FY2020 | -97.3% | +529.7 pp |
| FY2019 | -627.0% | — |
| FY2017 | -10474.3% | -9097.8 pp |
| FY2016 | -1376.4% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More XENE financial trends
XENE RevenueXENE Net incomeXENE Net marginXENE Gross profitXENE Gross marginXENE Operating incomeXENE Operating cash flowXENE Free cash flowXENE Capital expendituresXENE Return on equityXENE Stock buybacksXENE Dividends paidXENE Total assetsXENE Total liabilitiesXENE Shareholders’ equityXENE overview →